The Effects of Dietary Taurine Supplementation on Bone Mineral Density in Ovariectomized Rats
This study was performed to evaluate the effect of a diet rich in taurine (2.0 g/100 g) on bone metabolism in ovariectomized (OVX) rats. All rats were fed deionized water during the experimental period. Bone mineral density (BMD) and bone mineral content (BMC) of spine and femur were measured. Serum and urinary calcium and phosphorus content were determined. The levels serum osteocalcin and alkaline phosphatase (ALP) were used to assess bone formation. The rate of bone resorption was measured by the deoxypyridinoline (DPD) crosslink immunoassay and corrected for creatinine. Urinary Ca and P excretion, serum osteocalcin content, and the crosslink value were not significantly different between the Sham groups. The taurine supplemented, Sham group had higher spinal and femur BMC than those of the untreated control group, but the difference was not statistically significant. However, the taurine supplemented, Sham group had significantly higher spine and femur BMC per weight than those of the untreated control group. Within the OVX group, the taurine supplemented group had a lower crosslink value than the casein group. The taurine supplemented, OVX group had higher femur bone mineral content per weight than those of the control, OVX group, but the difference was not statistically significant. A study examining the long-term effect of taurine supplementation in humans is warranted.
KeywordsBone Mineral Density Sham Group Bone Mineral Content Short Bowel Syndrome Serum Osteocalcin
Unable to display preview. Download preview PDF.
- Furukawa S, Katto M, Kouyama H, Nishida I, Kikumori M, Taniguchi Y, Toda T., Araki H (1991) Repeated dose toxicity study of intravenous treatment with taurine for 13 weeks and recovery test for 5 weeks in rats. Jap Phar Thera 19:275–306Google Scholar
- Jeri WN (2005) Supplement: women and micronutrients:Addressing the gap throughout the life cycle: Osteoporosis: the role of micronutrients. Am. J. Clinical Nutrition 81:1232S–1239SGoogle Scholar
- Tangpricha M, Luo C, Fernandez-Estivariz LH, Gu N, Bazargan JM, Klapproth SV, Sitaraman JR, Galloway LM, Leader T R, Ziegler (2006) Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. JPEN 30:480–486Google Scholar
- Yakar S, Rosen CJ, Beamer WG (2002) Circulating levels of IGF-1 directly regulatebone growth and density. J ClinInvest 110:771–781Google Scholar